AXIM Biotechnologies, Inc.
Cash Flow Statement
| Line Item | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-10.1M | $-582.9K | $-89.2K | $-14.9K | $-2.8K |
| Depreciation & Amortization | $1.1K | $0 | — | — | — |
| Depreciation | $1.1K | $0 | — | — | — |
| Amortization | — | — | $10.0K | $5.5K | $832 |
| Stock-Based Compensation | $6.0M | $0 | — | — | — |
| Net Cash from Operating Activities | $-1.5M | $-339.0K | $-33.0K | $21.1K | $4.0K |
| Investing Activities | |||||
| Capital Expenditures | $-16.8K | $0 | — | — | — |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $-16.8K | $0 | — | $-100.0K | $0 |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $1.0M | $1.0M | $14.0K | $74.9K | $19.1K |
| Net Change in Cash | $-527.0K | $661.0K | $-19.0K | — | — |
| Free Cash Flow | $-1.5M | $-339.0K | — | — | — |